Biogen, Eisai End Two Late-Stage Trials for Alzheimer ’s Treatment

The widely expected move comes months after the companies scrapped trials of another Alzheimer ’s drug.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: Alzheimer's | Science